Gelesis Holdings, Inc. (NYSE:GLS – Get Rating)'s share price was up 0.4% during trading on Monday . The stock traded as high as $0.16 and last traded at $0.16. Approximately 185,100 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 386,034 shares. The stock had previously closed at $0.16.
Gelesis Trading Up 0.4 %
The company has a market capitalization of $11.63 million, a PE ratio of -0.11 and a beta of 0.88. The business's 50-day simple moving average is $0.23 and its 200-day simple moving average is $0.40.
Get Gelesis alerts:Institutional Investors Weigh In On Gelesis
Hedge funds and other institutional investors have recently made changes to their positions in the company. State Street Corp acquired a new stake in shares of Gelesis during the 1st quarter worth approximately $250,000. Northern Trust Corp acquired a new stake in Gelesis in the 1st quarter valued at $180,000. Goldman Sachs Group Inc. acquired a new stake in Gelesis in the 1st quarter valued at $103,000. Charles Schwab Investment Management Inc. acquired a new stake in Gelesis in the 1st quarter valued at $76,000. Finally, Virtu Financial LLC acquired a new stake in Gelesis in the 1st quarter valued at $73,000. Institutional investors and hedge funds own 16.71% of the company's stock.
About Gelesis
(Get Rating)
Gelesis Holdings Inc, a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation.
Featured Stories
- Get a free copy of the StockNews.com research report on Gelesis (GLS)
- Medtronic: Reversal In-Play For This High-Yield Stock
- Is it 'Game Over' for Roblox After Reporting March Metrics Miss?
- Is it Time to Take Profits in Chip Stocks?
- Will Stratasys Continue to be a Runaway Bride?
- Garrett Motion Inc. Skids on Results: Is it Time to Buy the Dip?
Receive News & Ratings for Gelesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelesis and related companies with MarketBeat.com's FREE daily email newsletter.
